Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Differential gene expression in mice liver following bulaquine administration


ABSTRACT: Global gene expression in livers of bulaquine treated mice was compared with control mice at different time points. Keywords: Time course Mice (Mus musculus) belonging to control and bulaquine-administered groups (n=4) were sacrificed. The livers were snap frozen in liquid nitrogen, and subsequently stored at -80ºC till further use. Liver samples were homogenized and total RNA was extracted with TRI reagent. 25 ug of total RNA was converted into labeled cDNA using CyScribe first strand cDNA labeling kit. The Cy5 and Cy3 labeled cDNAs were resuspended in Cyscribe Hyb buffer containing 10ug/ml sheared Salmon sperm DNA and 10ug/ml Yeast tRNA. The labeled samples were hybridized to the arrays and incubated for 16-18hrs at 42ºC. Fluorescent array images were collected for both Cy3 and Cy5 with molecular dynamics III scanner supported with ImageQuant v5.0. Image intensity data were extracted and analyzed with ArrayVision v8.0 analysis software. Background corrected data was LOWESS normalized and log ratios were calculated using Avadis v4. Replicate experiments were carried out in dye swap manner for each time point.

ORGANISM(S): Mus musculus

SUBMITTER: Srikanta Rath 

PROVIDER: E-GEOD-5980 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications

Identification of differentially expressed genes after acute exposure to bulaquine (CDRI 80/53) in mice liver.

Noel Sanjeev S   Sharma Sharad S   Shankar Rishi R   Rath Srikanta Kumar SK  

Basic & clinical pharmacology & toxicology 20080718 6


Therapeutic agents derived from 8-aminoquinoline possess potent activity against hepatic stages of plasmodia. Bulaquine (CDRI 80/53), an enamine analogue of primaquine and a relatively new derivative of 8-aminioquinoline, synthesized at the Central Drug Research Institute, Lucknow, India, has shown promising activity against hypnozoites of Plasmodium vivax and Plasmodium ovale. Moreover, it has been found to be three to four times safer than primaquine in pre-clinical studies. In this study, glo  ...[more]

Similar Datasets

2014-12-23 | E-GEOD-19157 | biostudies-arrayexpress
2010-06-11 | E-GEOD-4874 | biostudies-arrayexpress
2011-04-27 | E-GEOD-12716 | biostudies-arrayexpress
2008-06-04 | E-GEOD-11328 | biostudies-arrayexpress
2019-12-06 | PXD011068 | Pride
2019-05-23 | PXD010986 | Pride
2010-06-01 | E-GEOD-14774 | biostudies-arrayexpress
2021-03-02 | PXD024317 | Pride
2003-03-28 | GSE325 | GEO
2003-03-28 | GSE326 | GEO